SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-361415
Filing Date
2013-09-09
Accepted
2013-09-09 16:06:07
Documents
3
Period of Report
2013-09-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d595455d8k.htm 8-K 15496
2 EX-99.1 d595455dex991.htm EX-99.1 70621
3 GRAPHIC g595455contatus.jpg GRAPHIC 10106
  Complete submission text file 0001193125-13-361415.txt   101339
Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 131085713
SIC: 2834 Pharmaceutical Preparations